7:00 AM- 7:45 AM
Breakfast
8:00 AM- 12:00 PM
Welcome Remarks
Introductory Address
Amir Kalali, Chief Curator, CNS Summit
CNS Summit 2018 Keynote Session
Mary Lou Jepsen, Founder & CEO, Openwater
Myrtle Potter, Vant Operating Chair, Roivant Sciences
Eric Perakslis, Chief Science Officer, Datavant
Peter Bergethon, Head, Quantitative Medicine & Clinical Technologies, Biogen
Doug Schantz, Executive Director, Clinical Operations, AstraZeneca
Benjamine Liu, CEO, TrialSpark
Jacob LaPorte, Global Head, Digital Development, Novartis
Joris Van Dam, Head of Digital Therapeutics, Novartis
Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing, Novartis
Yuri Maricich, Chief Medical Officer & Head of Clinical Development, Pear Therapeutics
Ed Ikeguchi, Chief Medical Officer, AiCure
Kristin Milburn, Head of Healthcare, Headspace
Richie Etwaru, Founder & CEO, Hu-manity.co
CNS Summit 2018 Innovation Index
Top 10 Pharma Awardees of 2018 Innovation Index
Presented by Amir Kalali, Chief Curator, CNS Summit & Mike Rea, CEO, IDEA Pharma
12:00 pm- 1:00 pm
Innovation Showcase
(Lunch Provided)
Benjamin Vandendriessche, Chief Medical Officer, Byteflies
Chelsea Trengrove, Program Manager, Empatica
Ardy Arianpour, Co-Founder & CEO, Seqster
Mouli Narayanan, Founder & CEO, Zeblok
Joydeep Sarkar, Chief Analytics Officer, Holmusk
Moderated By Georgia Mitsi, Sunovion
1:00 pm- 1:30 pm
Solution Showcase
Chris Benko, CEO, Koneksa Health
Robert Ellis, CTO, Koneksa Health
1:45 pm- 3:15 pm
CNS Summit Parallel Sessions:
Session 1: Neuroscience
Emiliangelo Ratti, Senior Vice President, Global Head, Neuroscience, Takeda "Neuroscience at Takeda"
Kenneth Koblan, Head of Discovery and Global TMED, Sunovion
Karoly Nikolich, CEO, Alkahest
Phil Harvey, Leonard M. Miller Professor of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine
Alex Cohen, Louisiana State University
Gregory Strauss, University of Georgia
Co-Chair: Atul Mahableshwarkar, VP Clinical Development, BlackThorn Therapeutics
Co-Chair: Roger Bullock, Chief Medical Officer, Oryzon Genomics
Session 2: Should Pharma Care about Digital Therapeutics?
Yuri Maricich, CMO & Head, Clinical Development, Pear Therapeutics
Anil Jina, SVP, Head of Medical Affairs, Akili
Pravin Jadhav, R&D Innovation, Otsuka
Chair: Ed Cox, CEO, DThera Sciences
Session 3: Commercializing Innovation / Commercial Innovations
Daniel Levine, Director, Avant-Guide Institute
Peter Bach, Director, BioPharmaLogic
Luca Pani, VeraSci and University of Miami Miller School of Medicine
Robert Baurys, CEO, 83Bar
Melinda Decker, Former Head of Oncology & Immuno-Oncology, AstraZeneca
Don Apruzzese, CCO, Atentiv
Milind Kamolkar, Chief Digital Officer, Sanofi
John Nosta, President, NostaLab
Chair: Mike Rea, CEO, IDEA Pharma
Session 4: Virtual Trials
John Reites, Chief Product Officer, THREAD
Tomasz Sablinski, Co-Founder & CEO, Transparency Life Sciences
Michelle Longmire, CEO, Medable
Adam Butler, Senior Vice President, Bracket
Noah Craft, Co-Founder & CEO, Science 37
Chair: Joe Dustin, Director, Mobile Health, Medidata
Session 5: How Can Sites Thrive in Changing Research Landscapes
Irena Webster, Director, Clinical Development, Sage Therapeutics
Brian Craig, CEO, Pillar Clinical Research
Christian Burns, President, ClinEdge
Shishuka Malhotra, Founder & Medical Director, Neuro-Behavioral Clinical Research
Chair: Leslie Franceschi, Project Director, Syneos Health
3:30 pm- 5:00 pm
One-to-One Networking Sessions
5:00 pm- 7:00 pm
Evening Reception, Posters & Exhibits